Gabriela Alperovich, MD, PhD

Dr. Alperovich joined InflaRx from CSL Vifor, where she served most recently as Executive Director, Global Clinical Lead for Cardiovascular and Renal, overseeing the company's cardiovascular and renal clinical development programs and leading a global team of physicians and clinical scientists. Over more than 20 years in the industry, she has held clinical development and medical affairs leadership roles at CSL Vifor, AbbVie and Bristol-Myers Squibb, among others, leading Phase 2/3 registrational programs across multiple indications - including IgA nephropathy, focal segmental glomerulosclerosis (FSGS) and kidney transplant - with successful regulatory submissions and approvals, and taking direct responsibility for assets through lifecycle management and post-approval commitments.

Dr. Alperovich is board certified in Internal Medicine and Nephrology and holds a PhD in kidney transplant from the University of Barcelona.